You are here

Home » Content

Nar'ın (Punica granatum) terapötik etkileri

Therapeutic use of pomegranate (Punica granatum)

Journal Name:

  • Türkiye Aile Hekimliği Dergisi

Publication Year:

  • 2010
DOI: 
doi:10.2399/tahd.10.146

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
The pomegranate, Punica granatum L., an ancient, mystical, and highly distinctive fruit, is the predominant member of two species comprising the Punicaceae family. The pomegranate has been widely consumed in many different cultures for thousands of years, largely without incidents, and thus is considered generally safe by the general public. The pomegranate tree, Punica granatum, especially its fruit, possesses a vast ethnomedical history and represents a phy-tochemical reservoir of heuristic medicinal value. The tree/fruit can be divided into several anatomical compartments: seed, juice, peel, leaf, flower, bark, and roots, each of which has interesting pharma-cologic activity. Juice and peels, for example, possess potent antiox-idant properties, while juice, peel and oil are all weakly estrogenic. However, the use of juice, peel and oil have also been shown to pos¬sess anticancer activities, including interference with tumor cell pro¬liferation, cell cycle, invasion and angiogenesis. In the human and animal studies, pomegranate has been shown to exert significant antiatherogenic, antioxidant, anticarcinogenic and anti-inflammato¬ry effects. It is possible to use pomegranate in the prevention of can¬cer, cardiovascular disease, diabetes and ultraviolet radiation-induced skin damage. Increasing body of evidence has underscored the cancer preventive efficacy of pomegranate both in vitro and in vivo animal models. Currently, numerous clinical trials are in progress exploring the therapeutic potential of pomegranate extracts.
Bookmark/Search this post with
Abstract (Original Language): 
Punicaceae ailesinin önemli bir üyesi olan nar; (Punica granatum) antik dönemden beri tanınan, mistik özelliklere sahip, diğerlerinden oldukça farklı bir meyvedir. Nar, binlerce yıldır farklı kültürler tarafından oldukça yaygın olarak kullanılan, herhangi bir ciddi yan etkisi olmayan ve toplum tarafında oldukça güvenli kabul edilen bir bitkidir. Nar ağacı özellikle de meyvesi halk hekimliğinde yeri olan, medikal değeri keşfedilmesi gereken bir fitokimyasal kaynaktır. Nar ağacı ve meyvesi, değişik ilgi çekici farmakolojik etkilere sahip anatomik bölümlerden oluşur; çekirdek, nar suyu, kabuk, yaprak, çiçek, ağaç kabuğu ve kök. Nar suyu ve meyve kabuğu güçlü antioksidan etki gösterir, nar suyu, kabuğu ve yağı zayıf ös-trejenik etkilidir. Nar suyu, kabuğu ve yağının tümör hücre çoğal¬ması, döngüsü, invazyonu ve anjiogenez ile etkileşerek antikanser aktivite gösterdiği kanıtlanmıştır. insan ve hayvan çalışmaları, na¬rın antiaterojenik, antioksidan, antikanserojenik ve antiinflamatu-var etkilerini göstermiştir. Kanser, kardiyovasküler hastalıklar, di¬yabet ve ultraviyolenin zararlı etkilerinden koruyucu olarak kulla¬nılabilme potansiyeli vardır. in vitro ve in vivo hayvan modellerin¬de artan sayıda deney, narın, kanser tedavisinde etkili olduğunu kanıtlamaktadır. Günümüzde, nar ekstrelerinin terapötik kullanımlarıyla ilişkili birçok çalışma sürdürülmektedir.
FULL TEXT (PDF): 
PDF icon arastrmx_116859_14_pp_146-153.pdf
  • 3
146-153
  • Turkish

REFERENCES

References: 

1. Jurenka J. Therapeutic applications of pomegranate (Punica granatum L.). Alternative Medicine Review 2008; 13:128-44.
2. Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol 2007; 109: 177-206.
3. Afaq F, Saleem M, Krueger CG, Reed JD, Mukhtar H. Anthocyanin-and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Int J Cancer 2005; 113:423-33.
4. Xu J, Guo CJ, Yang JJ ve ark. Intervention of antioxidant system function of aged rats by giving fruit juices with different antioxidant capacities. Zhonghua Yu Fang Yi Xue Za Zhi 2005; 39; 80-3.
5. Perez-Icente A, Gil-Izquierdo A, Garcia-Viguera C. In vitro gastrointesti¬nal digestion study of pomegranate juice phenolic compounds, antho-cyanins, and vitamin C. J Agric Food Chem2002; 50: 2308-12.
6. Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM, Kader AA.
Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 2000; 48: 4581-9.
7. Cerda B, Espin JC, Parra S, Martinez P, Tomas-Barberan FA. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eur J Nutr 2004;
43: 205-20.
8. Seeram NP, Lee R, Heber D. Bioavailability of ellagic acid in human plas¬ma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clin Chim Acta 2004; 348: 63-8.
9. Seeram NP, Aviram M, Volkova N ve ark. Dietary polyphenols derived from pomegranates are potent antioxidants: evaluation in various in vitro models of antioxidation. 228th National Meeting of the American
Chemical Society, 2004; 67: 49-56.
10. Seeram NP, Henning SM, Zhang Y, Suchard M, Li Z, Heber D. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J Nutr 2006; 136: 2481-5.
11. Basu A, Penugonda K. Pomegranate juice: a heart-healthy fruit juice. Nutrition Reviews 67: 49-56.
12. Ignarro LJ, Byrns RE, Sumi D, de Nigris F, Napoli C. Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biolog¬ical actions of nitric oxide. Nitric Oxide 2006; 15: 93-102.
13. Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H.
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate
cancer. Proc Natl Acad Sci2005; 102: 14813-8.
14. Lansky EP, Harrison G, Froom P, Jiang WG. Pomegranate (Punica grana-tum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across matrigel. Invest New Drugs 2005; 23:
121-2.
152
Yılmaz B, Usta C | Nar'ın (Punica granatum) terapötik etkilen
15. Malik A, Mukhtar H. Prostate cancer prevention through pomegranate fruit. Cell Cycle 2006; 5:371-3.
16. Pantuck AJ, Leppert JT, Zomorodian N ve ark. Phase II study of pome¬granate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res 2006; 12:4018-26.
17. Seeram NP, Aronson WJ, Zhang Y ve ark. Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J Agric Food Chem 2007; 55: 7732-7.
18. Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, Heber D.
Pomegranate juice, total pomegranate ellagitannins, and punicalagin sup¬press inflammatory cell signaling in colon cancer cells. J Agric Food Chem
2006; 54: 980-5.
19. Toi M, Bando H, Ramachandran C ve ark. Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis 2003; 6: 121-8.
20. Mehta R, Lanksy EP. Breast cancer chemopreventive properties of pome¬granate (Punica granatum) fruit extracts in a mouse mammary organ culture. Eur J Cancer Prev 2004; 13: 345-8.
21. Kim ND, Mehta R, Yu W ve ark. Chemopreventive and adjuvant thera¬peutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat 2002; 71: 203-17.
22. Jeune MA, Kumi-Diaka J, Brown J. Anticancer activities of pomegranate extracts and genistein in human breast cancer cells. J Med Food2005; 8: 469¬75.
23. Khan N, Hadi N, Afaq F, Syed DN, Kweon MH, Mukhtar H.
Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis
2007; 28: 163-73.
24. Khan N, Afaq F, Kweon M-H, Kim KM, Mukhtar H. Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Cancer Res2007; 67: 3475-82.
25. Syed DN, Malik A, Hadi N, Sarfaraz S, Afaq F, Mukhtar H.
Photochemopreventive effect of pomegranate fruit extract on UVA-medi-ated activation of cellular pathways in normal human epidermal ker-atinocytes. Photochem Photobiol 2006; 82: 398-405.
26. Afaq F, Malik A, Syed D, Maes D, Matsui MS, Mukhtar H. Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogenactivat-ed protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes. Photochem Photobiol 2005; 81: 38-45.
27. Hora JJ, Maydew ER, Lansky EP, Dwivedi C. Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice. J Med Food
2003; 6: 157-61.
28. Aslam MN, Lansky EP, Varani J. Pomegranate as a cosmeceutical source: pomegranate fractions promote proliferation and procollagen synthesis and inhibit matrix metalloproteinase-1 production in human skin cells. J Ethnopharmacol 2006; 103: 311-8.
29. Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of athero¬sclerosis. J Atheroscler Thromb 2003; 10: 63-71.
30. Aviram M, Volkova N, Coleman R, ve ark. Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: studies in vivo in athero¬sclerotic apolipoprotein e-deficient (E0) mice and in vitro in cultured macrophages and lipoproteins. J Agric Food Chem2008; 56: 1148-57.
31. Aviram M, Dornfeld L, Rosenblat M, ve ark. Pomegranate juice consump¬tion reduces oxidative stress, atherogenic modifications of LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipopro-tein E-deficient mice. Am J Clin Nutr 2000; 71: 1062-76.
32. Aviram M, Dornfeld L, Kaplan M ve ark. Pomegranate juice flavonoids inhibit LDL oxidation and cardiovascular disease: studies in atherosclerot¬ic mice and in humans. Drugs Exp Clin Res 2002; 28: 49-62.
33. Aviram M. Pomegranate juice as a major source for polyphenolic flavonoids and it is most potent antioxidant against LDL oxidation and atherosclero¬sis. Free Radic Res2002; 36: 71-3.
34. Kaplan M, Hayek T, Raz A, ve ark. Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cho¬lesterol accumulation and development of atherosclerosis. J Nutr 2001; 131:2082-9.
35. Sumner MD, Elliott-Eller M, Weidner G, ve ark. Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart
disease. Am J Cardiol2005; 96: 810-4.
36. Rosenblat M, Hayek T, Aviram M. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages.
Atherosclerosis2006; 187: 363-71.
37. Squillaci G, Di Maggio G. Acute morbidity and mortality from decoctions of the bark of Punica granatum. Bollettino Societa Italiana Biologia Sperimentale
1946; 1095-6.
38. Vidal A, Fallarero A, Pena B.R, ve ark. Studies on the toxicity of punica granatum L. (Punicaceae) whole fruit extracts. Journal of Ethnopharmacology
2003; 89: 295-300.
39. Igea JM, Cuesta J, Cuevas M, ve ark. Adverse reaction to pomegranate ingestion. Allergy 1991; 46: 472-4.
40. Gaig P, Bartolome B, Lleonart R, Garcia-Ortega P, Palacios R, Richart, C. Allergy to pomegranate (Punica granatum). Allergy 1999; 54: 287-8.
41. Hegde VL, Mahesh PA, Venkatesh YP. Anaphylaxis caused by mannitol in pomegranate (Punica granatum). Allergy and Clinical Immunology Interna-
tional2002; 14: 37-9.
42. Ghadirian, P. Food habits of the people of the Caspian Littoral of Iran in relation to esophageal cancer. Nutrition and Cancer 1987; 9: 147-57.
43. Ghadirian P, Ekoe JM, Thouez JP. Food habits and esophageal cancer: an overview. Cancer Detection and Prev 1992; 16: 163-8.

Thank you for copying data from http://www.arastirmax.com